Fernanda F. Ramos

Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis

Daniel Dias, Patrícia A.F. Ribeiro, Vívian T. Martins et al. · Cellular Immunology · 2017 · 47 citations

Parasitic Protozoa, Leishmania Infantum, Pathogenesis +7

Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis

Daniel Dias, Patrícia A.F. Ribeiro, Vívian T. Martins et al. · Translational research · 2018 · 47 citations

Vaccination, Mucosal Vaccination, Leishmania Infantum +10

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias et al. · npj Vaccines · 2020 · 47 citations · Full text

Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis

Áquila S.B. Portela, Lourena E. Costa, Beatriz C.S. Salles et al. · Immunobiology · 2017 · 40 citations

Inflammation, Immune Biomarkers, Autoimmune Disease +15

Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion

Fernanda Ludolf, Fernanda F. Ramos, Flávia Fonseca Bagno et al. · Science Advances · 2022 · 33 citations · Full text

Vaccination, Viral Diagnostics, Covid-19 Immune Conversion +13